Clinical trial
Pharmacokinetics of Mmf and Valganciclovir
NCT00189150 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00189150 |
|---|---|
| Title | Pharmacokinetics of Mmf and Valganciclovir |
| Official title | Pharmacokinetics of Mycophenolate Mofetil Alone and in Combination With Valganciclovir in Renal and Heart Transplant Recipients |
| Lead sponsor | University of Michigan, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplant Recipient, Heart Transplant Recipient |
| Intervention type | Drug |
| Interventions | Mycophenolate mofetil, Valganciclovir |
| Enrollment | 16 |
| Start date | Apr 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | May 25, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: